<DOC>
<DOCNO>
EP-0004913
</DOCNO>
<TEXT>
<DATE>
19791031
</DATE>
<IPC-CLASSIFICATIONS>
C12R-1/20 C12N-1/00 C12N-15/00 C12N-1/20 C12P-33/16 C12N-1/02 C12R-1/06 C12R-1/07 C12R-1/425 C12R-1/465 C12N-15/01 C12P-33/00 C12R-1/15 C12R-1/13 C12R-1/025 C12R-1/365 C07J-9/00 <main>C07J-9/00</main> C12R-1/32 
</IPC-CLASSIFICATIONS>
<TITLE>
process for the selective degradation of side chains of steroids and for the preparation of the appropriate defective blocked microorganism mutants and new microorganism strains.
</TITLE>
<APPLICANT>
henkel kgaa de  <sep>henkel kommanditgesellschaft auf aktien<sep>henkel kommanditgesellschaft auf aktien40191 düsseldorfde<sep>henkel kommanditgesellschaft auf aktien<sep>
</APPLICANT>
<INVENTOR>
hill frank dr<sep>preuss wolfgang dr<sep>schindler joachim dr<sep>schmid rolf dr<sep>struve alfred dr<sep>hill, frank, dr.<sep>preuss, wolfgang, dr.<sep>schindler, joachim, dr.<sep>schmid, rolf, dr.<sep>struve, alfred, dr.<sep>hill, frank, dr.schlesienstrasse 23d-4020 mettmann-obschwarzbachde<sep>preuss, wolfgang, dr.finkenweg 12d-4019 monheim rhld.de<sep>schindler, joachim, dr.am eichelkamp 158d-4010 hilden rhldde<sep>schmid, rolf, dr.am nettchesfeld 30d-4000 düsseldorf 13de<sep>struve, alfred, dr.am eichelkamp 53d-4010 hilden rhld.de<sep>hill, frank, dr.<sep>preuss, wolfgang, dr. <sep>schindler, joachim, dr.  <sep>schmid, rolf, dr.<sep>struve, alfred, dr.<sep>hill, frank, dr.schlesienstrasse 23d-4020 mettmann-obschwarzbachde<sep>preuss, wolfgang, dr.finkenweg 12d-4019 monheim rhld.de<sep>schindler, joachim, dr.am eichelkamp 158d-4010 hilden rhldde<sep>schmid, rolf, dr.am nettchesfeld 30d-4000 düsseldorf 13de<sep>struve, alfred, dr.am eichelkamp 53d-4010 hilden rhld.de<sep>
</INVENTOR>
<ABSTRACT>
For the preparation of 17-C steroid-α-propionic acid compounds by microbial side chain dismantling to 17-C side chain steroid substrates, selected microorganism wild tribes of a multi-stage mutation and selection are subjected to selected mutating mutation and selection in a predetermined manner.The recovered mutant strains are enabled, the desired compounds, z.b.Δ-4 BNC and / or Δ-1.4 BNC in high yields also in the absence of the growth and / or steroitring reduction inhibiting inhibitors to provide inhibitors.Particularly suitable game strains and mutants as well as their selection, recovery and application are described.
</ABSTRACT>
</TEXT>
</DOC>
